Regarding “Intra-articular Injection of Tranexamic Acid Reduced Postoperative Hemarthrosis in Arthroscopic Anterior Cruciate Ligament Reconstruction: A Prospective Randomized Study”

We read with great interest the recently published article by Chiang et  al.1 on the use of tranexamic acid (TXA) in arthroscopic anterior cruciate ligament (ACL) reconstruction. Previously, the drug had been successfully used to control bleeding and reduce total blood loss in non-orthopaedic procedures2,3; more recently, several high-quality studies have addressed the use of TXA in joint replacement, and its efficacy in this setting is now widely recognized.4-6 The benefits of TXA should be studied for other orthopaedic procedures that may take advantage of reduced bleeding, such as closed-joint surgery, in which hemarthrosis is a cause of pain, functional lim itation, and difficulty in rehabilitation.

Source: Arthroscopy - Journal of Arthroscopic and Related Surgery - October 31, 2019 Category: Surgery Authors: Riccardo Gomes Gobbi, Pedro Nogueira Giglio, Camilo Partezani Helito, Jos é Ricardo Pécora Tags: Letter to the Editor Source Type: research